Uncategorized
American Diabetes Association updates guidelines for diabetic retinopathy
The American Diabetes Association updated its guidelines for the diagnosis and treatment of diabetic retinopathy for the first time since its last position statement on the condition in 2002, according to a report. The American Diabetes Association confirmed the importance of anti-VEGF agents in the treatment of both diabetic macular edema and proliferative diabetic retinopathy. Anti-VEGFs may be a viable alternative or adjunct to panretinal laser photocoagulation in eyes with PDR through at least 2 years.